🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

322 results for “Hospital Authority, Hong Kong” Clear

  1. atosiban

    Hospital Authority, Hong Kong

    Repeated Implantation Failure

    small molecule completed

    1 trial

  2. fentanyl

    Hospital Authority, Hong Kong

    Anesthesia, Spinal

    small molecule completed

    1 trial

  3. metformin, topiramate

    Hospital Authority, Hong Kong

    Obesity

    small molecule completed

    1 trial

  4. morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    small molecule completed

    1 trial

  5. oral nutritional supplement

    Hospital Authority, Hong Kong

    Gastric Cancer

    other completed

    1 trial

  6. plasmalyte solution

    Hospital Authority, Hong Kong

    Cardiac Surgery

    small molecule completed

    1 trial

  7. probiotic cocktail capsules

    Hospital Authority, Hong Kong

    Vancomycin-Resistant Enterococci

    other active

    1 trial

  8. probiotics

    Hospital Authority, Hong Kong

    Parkinson's Disease (PD)

    other terminated

    1 trial

  9. rabeprazole plus aspirin versus rabeprazole plus clopidogrel

    Hospital Authority, Hong Kong

    Gastric Ulcer

    small molecule active

    1 trial

  10. warfarin

    Hospital Authority, Hong Kong

    Deep Venous Thromboembolism

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources